Search Results
Displaying 141 - 150 of 1153
… of muscle tone. Some congenital myopathies may not show symptoms until infancy or childhood. Myopathy happens when … types of congenital myopathy with varying severity. Some symptoms may remain stable or progress slowly. The following is a range of symptoms: Lack of muscle control and weakness Hard time …
… on eligibility Contact your Program Director for more information. R35 Policies for Awardees Policy for … Award (RPA) [R35] solicitation and we strongly encourage all eligible PIs to apply! If you have any questions about … for consideration by the National Advisory Neurological Disorders and Stroke Council in January 2025, with the …
… R33 phase is mainly based on completing go/no-go milestone(s) at the end of the R61 phase. All funding opportunities … This type of mechanism involves NIH program staff's participation in developing the project milestones and … lead to an Investigation Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to support a small …
… What is multiple system atrophy? Multiple system atrophy (MSA) is a progressive neurodegenerative disorder … functions such as blood pressure or digestion). MSA was formerly known as Shy-Drager syndrome, … they’re evaluated by a doctor: Parkinsonian type MSA (MSA-P) has primary symptoms similar to Parkinson's disease (such …
… Each fiscal year (FY), NINDS establishes a payline for all percentiled RPGs (e.g. R01, R03, R15, and R21) and funds all applications that score within that payline with very … (FY17 payline: 12 th percentile). Figure 1 illustrates all competing R01 applications, grants and bridge awards …
… Each fiscal year (FY), NINDS establishes a payline for all percentiled RPGs (e.g. R01, R03, R15, and R21) and funds all applications that score within that payline with very … (FY16 payline: 15 th percentile). Figure 1 illustrates all competing R01 applications, grants and bridge awards …
… of research on the brain and nervous system, including disorders such as SC. NIH supports new research to better understand, diagnose, and treat SC. For more information on research about SC, check NIH RePORTER , a … better ways to safely detect, treat, or prevent disease. All types of participants are needed—those who are healthy or …
On this page
The NINDS Translational Biomarker ProgramThe NINDS Biomarker Program is focused on improving the quality and efficiency of neurotherapeutic clinical research by supporting rigorous biomarker development and validation. In order to achieve this goal, the program: 1) promotes rigorous biomarker identification and validation through milestone-driven funding opportunities…
… page What is cytomegalovirus? Cytomegalovirus (CMV) is a common virus that infects between 50 to 80 percent of all adults in the U.S. by age 40. CMV is in the same family of viruses … birth. Some people never develop symptoms. People with a compromised immune system may have more severe forms of …
… cutting-edge medical devices for diagnosing and treating disorders of the nervous system. The mission of the program … neuralgia, peripheral neuropathy associated with Sjogren’s syndrome, burning mouth syndrome) and non-neurological (e.g., … BP MedTech-funded Incubator Hubs are listed first below. All other resources will be provided through the three …